Écrit par WHO | 09 Mai 2016

6 May 2016, Tunis, Tunisia -- WHO expresses great concern over the death of 12 newborns in the Sabah Medical Centre neonatal intensive care unit in Sabha, southern Libya. The deaths occurred as a result of a bacterial infection and lack of specialized health staff to provide medical care.

“These tragic deaths occurred as a result of easily preventable causes, and point to the major...

Écrit par WHO | 06 Mai 2016

A "mild" illness takes off

In early February 2015, doctors in the impoverished northeastern part of Brazil noticed a surge in the number of people complaining about a mild illness, with and without fever, characterized by rash, fatigue, joint pains, and red eyes. The illness was brief and recovery was spontaneous. A mild form of dengue, a mosquito-borne disease hyperendemic throughout the...

Écrit par Relmada Therapeutics | 06 Mai 2016

Data show that d-Methadone produces antidepressant activity comparable to ketamine after single dose administration in a well-validated model.



NEW YORK -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced the results of an in vivo study showing that administration of d-Methadone (REL-1017)...

Écrit par Olivier Cigolotti | 04 Mai 2016

Olivier Cigolotti Sénateur de la Haute-Loire «Aucun Français ne devrait mettre sa vie en danger pour quelques euros !»



Olivier Cigolotti, sénateur de la Haute-Loire, est intervenu dans le cadre du débat sur la réglementation des essais cliniques. Le sénateur a interpelé la ministre...